• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥美拉唑不同给药方案对幽门螺杆菌阴性CYP2C19纯合子广泛代谢者的抑酸作用:哪种方案效果最强?

Acid-suppressive effects of various regimens of omeprazole in Helicobacter pylori-negative CYP2C19 homozygous extensive metabolizers: which regimen has the strongest effect?

作者信息

Shimatani Tomohiko, Kuroiwa Tomoko, Moriwaki Mutsuko, Xu Jing, Tazuma Susumu, Inoue Masaki

机构信息

Department of General Medicine, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

出版信息

Dig Dis Sci. 2007 Oct;52(10):2826-32. doi: 10.1007/s10620-006-9643-x. Epub 2007 Apr 5.

DOI:10.1007/s10620-006-9643-x
PMID:17410461
Abstract

To achieve more potent and long-lasting acid suppression, omeprazole was administered for 7 days in 5 regimens: 10, 20, and 40 mg once daily (od), and 10 and 20 mg twice daily (bid), in 7 healthy Helicobacter pylori-negative CYP2C19 homozygous extensive metabolizers, and intragastric pH was continuously measured. The median intragastric pH and percent time pH > 4.0 for 24 hours increased dose dependently with 10, 20, and 40 mg od. Ten and 20 mg bid wre comparable to 20 and 40 mg od, respectively. Concerning percent time pH > 4.0 in the nighttime (20:00-8:00 hours), 20 mg bid was significantly superior to 40 mg od (P < .05). In 4 of the 5 regimens, all 7 subjects had nocturnal acid breakthrough, whereas with 20 mg bid it occurred in only 3. We concluded that, considering nighttime acid suppression, omeprazole 20 mg bid had the strongest effect.

摘要

为实现更强效、持久的抑酸效果,对7名健康的细胞色素P450 2C19纯合子广泛代谢者采用5种方案给予奥美拉唑治疗7天:每日1次(od)10、20和40毫克,以及每日2次(bid)10和20毫克,并持续测量胃内pH值。胃内pH值中位数以及24小时内pH>4.0的时间百分比随每日1次10、20和40毫克剂量增加而呈剂量依赖性升高。每日2次10和20毫克分别与每日1次20和40毫克相当。关于夜间(20:00 - 8:00时)pH>4.0的时间百分比,每日2次20毫克显著优于每日1次40毫克(P <.05)。在5种方案中的4种里,所有7名受试者均出现夜间酸突破,而每日2次20毫克方案中仅3人出现。我们得出结论,考虑到夜间抑酸效果,每日2次20毫克奥美拉唑效果最强。

相似文献

1
Acid-suppressive effects of various regimens of omeprazole in Helicobacter pylori-negative CYP2C19 homozygous extensive metabolizers: which regimen has the strongest effect?奥美拉唑不同给药方案对幽门螺杆菌阴性CYP2C19纯合子广泛代谢者的抑酸作用:哪种方案效果最强?
Dig Dis Sci. 2007 Oct;52(10):2826-32. doi: 10.1007/s10620-006-9643-x. Epub 2007 Apr 5.
2
Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19.雷贝拉唑、奥美拉唑和兰索拉唑在降低剂量和标准剂量下的抑酸作用:细胞色素P450 2C19纯合子广泛代谢者的交叉对照研究
Clin Pharmacol Ther. 2006 Jan;79(1):144-52. doi: 10.1016/j.clpt.2005.09.012.
3
Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19.高剂量兰索拉唑对细胞色素P4502C19纯合子广泛代谢者胃内pH值的影响。
Clin Pharmacol Ther. 2001 Nov;70(5):484-92. doi: 10.1067/mcp.2001.119721.
4
Initial 48-hour acid inhibition by intravenous infusion of omeprazole, famotidine, or both in relation to cytochrome P450 2C19 genotype status.通过静脉输注奥美拉唑、法莫替丁或两者联合进行的初始48小时酸抑制与细胞色素P450 2C19基因型状态的关系。
Clin Pharmacol Ther. 2006 Nov;80(5):539-48. doi: 10.1016/j.clpt.2006.08.010.
5
Which has superior acid-suppressive effect, 10 mg omeprazole once daily or 20 mg famotidine twice daily? Effects of single or repeated administration in Japanese Helicobacter pylori-negative CYP2C19 extensive metabolizers.每日一次服用10毫克奥美拉唑与每日两次服用20毫克法莫替丁相比,哪种药物的抑酸效果更佳?对日本细胞色素P450 2C19基因野生型幽门螺杆菌阴性患者单次或重复给药的效果。
Dig Dis Sci. 2007 Feb;52(2):390-5. doi: 10.1007/s10620-006-9490-9. Epub 2007 Jan 9.
6
Rabeprazole 10 mg twice daily is superior to 20 mg once daily for night-time gastric acid suppression.雷贝拉唑10毫克每日两次在夜间胃酸抑制方面优于20毫克每日一次。
Aliment Pharmacol Ther. 2004 Jan 1;19(1):113-22. doi: 10.1046/j.1365-2036.2003.01821.x.
7
Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism.奥美拉唑对胃内pH值和血浆胃泌素的影响取决于CYP2C19基因多态性。
Gastroenterology. 2000 Sep;119(3):670-6. doi: 10.1053/gast.2000.16515.
8
CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.CYP2C19基因分型对奥美拉唑治疗幽门螺杆菌感染疗效的影响
Clin Pharmacol Ther. 1999 Nov;66(5):528-34. doi: 10.1016/S0009-9236(99)70017-2.
9
CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans.CYP2C19基因分型状态及奥美拉唑对人体胃内pH值的影响。
Clin Pharmacol Ther. 1999 May;65(5):552-61. doi: 10.1016/S0009-9236(99)70075-5.
10
Effects of CYP2C19 genetic polymorphism on the pharmacokinetics and pharmacodynamics of omeprazole in Chinese people.CYP2C19基因多态性对奥美拉唑在中国人群中药代动力学和药效学的影响。
J Clin Pharm Ther. 2007 Oct;32(5):517-24. doi: 10.1111/j.1365-2710.2007.00851.x.

引用本文的文献

1
Proton pump inhibitors: an update of their clinical use and pharmacokinetics.质子泵抑制剂:临床应用及药代动力学的最新进展
Eur J Clin Pharmacol. 2008 Oct;64(10):935-51. doi: 10.1007/s00228-008-0538-y. Epub 2008 Aug 5.

本文引用的文献

1
Review article: putting immediate-release proton-pump inhibitors into clinical practice--improving nocturnal acid control and avoiding the possible complications of excessive acid exposure.
Aliment Pharmacol Ther. 2005 Dec;22 Suppl 3:31-8. doi: 10.1111/j.1365-2036.2005.02712.x.
2
Effect of omeprazole 10 mg on intragastric pH in three different CYP2C19 genotypes, compared with omeprazole 20 mg and lafutidine 20 mg, a new H2-receptor antagonist.与奥美拉唑20毫克和新型H2受体拮抗剂拉呋替丁20毫克相比,10毫克奥美拉唑对三种不同CYP2C19基因型患者胃内pH值的影响。
Aliment Pharmacol Ther. 2003 Dec;18(11-12):1149-57. doi: 10.1046/j.1365-2036.2003.01804.x.
3
The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity.每日两次口服奥美拉唑并于睡前补充使用H2阻滞剂对夜间食管及胃酸分泌的抑制效果。
Aliment Pharmacol Ther. 2003 Jun 15;17(12):1553-8. doi: 10.1046/j.1365-2036.2003.01594.x.
4
The effects of lansoprazole on erosive reflux oesophagitis are influenced by CYP2C19 polymorphism.兰索拉唑对糜烂性反流性食管炎的疗效受细胞色素P450 2C19基因多态性的影响。
Aliment Pharmacol Ther. 2003 Apr 1;17(7):965-73. doi: 10.1046/j.1365-2036.2003.01539.x.
5
Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.在日本,克拉霉素耐药性和CYP2C19基因多态性对基于兰索拉唑或雷贝拉唑的三联疗法治疗幽门螺杆菌感染疗效的影响。
Eur J Gastroenterol Hepatol. 2003 Jan;15(1):27-33. doi: 10.1097/00042737-200301000-00006.
6
Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole.细胞色素P4502C19基因分型差异对兰索拉唑治疗胃食管反流病治愈率的影响。
Clin Pharmacol Ther. 2002 Oct;72(4):453-60. doi: 10.1067/mcp.2002.127637.
7
Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis.洛杉矶分级C级和D级反流性食管炎患者主要存在夜间酸反流。
J Gastroenterol Hepatol. 2001 Nov;16(11):1191-6. doi: 10.1046/j.1440-1746.2001.02617.x.
8
Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.CYP2C19基因分型差异对质子泵抑制剂、阿莫西林和克拉霉素三联疗法治疗幽门螺杆菌感染治愈率的影响。
Clin Pharmacol Ther. 2001 Mar;69(3):158-68. doi: 10.1067/mcp.2001.113959.
9
Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.综述文章:质子泵抑制剂的药代动力学、抑酸作用及疗效比较
Aliment Pharmacol Ther. 2000 Aug;14(8):963-78. doi: 10.1046/j.1365-2036.2000.00788.x.
10
CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans.CYP2C19基因分型状态及奥美拉唑对人体胃内pH值的影响。
Clin Pharmacol Ther. 1999 May;65(5):552-61. doi: 10.1016/S0009-9236(99)70075-5.